580
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically

, , , &
Pages 340-344 | Received 10 Dec 2010, Accepted 25 Apr 2011, Published online: 30 May 2011

References

  • Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve. 1995;18:741–52.
  • Geser F, Brandmei NJ, Kwong LK, Martinez-Lage M, Elman L, McCluskey L, . Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol. 2008;65:636–41.
  • Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol. 2009;187:761–72.
  • Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65:S3–9.
  • Bogaert E, d'Ydewalle C, van den Bosch L. Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanisms to therapeutic target. CNS & Neurol Disord Drug Targets. 2010;9:297–304.
  • Siciliano G, Carlesi C, Pasquali L, Piazza S, Pietracupa S, Fornai L, . Clinical trials for neuroprotection in ALS. CNS & Neurol Disord Drug Targets. 2010;9:305–13.
  • van den Bosch L, van Damme P, Bogaert E, Robberech W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim Biophys Acta. 2006;1762:1068–82.
  • van Damme P, Leyssen M, Callewaert G, Robberecht W, van den Bosch L. The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis. Neurosci Lett. 2003;343:81–4.
  • Tortarolo M, Grignaschi G, Calvaresi N, Zennaro E, Spaltro G, Colovic M, . Glutamate AMPA receptors change in motor neurons of SOD1-G93A transgenic mice and their inhibition by a non-competitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J Neurosci Res. 2006;83:134–46.
  • Howes JF, Bell C. Talampanel. Neurotherapeutics. 2007;4: 126–9.
  • Pascuzzi RM, Shefner J, Chappell AS, Bjerke JS, Tamura R, Chaudhry V, . A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11:266–71.
  • Paizs M, Engelhardt JI, Katarova Z, Siklós L. Hypoglossal motor neurons display a reduced calcium increase after axotomy in mice with up-regulated parvalbumin. J Comp Neurol. 2010;518:1946–61.
  • Domoki F, Bari F, Nagy K, Busija DW, Siklós L. Diazoxide prevents mitochondrial swelling and Ca2+ accumulation in CA1 pyramidal cells after cerebral ischaemia in newborn pigs. Brain Res. 2004;1019:97–104.
  • Vígh L, Smith RG, Soós J, Engelhardt JI, Appel SH, Siklós L. Sublethal dose of 4-hydroxynonenal reduces intracellular calcium in surviving motor neurons in vivo. Acta Neuropathol. 2005;109:567–75.
  • Pizzasegola C, Caron I, Daleno C, Ronchi A, Minoia C, Carri MT, . Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph Lateral Scler. 2009;10:221–8.
  • Beers DR, Ho B-K, Siklós L, Alexianu ME, Mosier DR, Mohamed AH, . Parvalbumin overexpression alters immune-mediated increases in intracellular calcium, and delays disease onset in a transgenic model of familial amyotrophic lateral sclerosis. J Neurochem. 2001;79:499–509.
  • Siklós L, Engelhardt JI, Alexianu ME, Gurney ME, , SiddiqueTAppel SH. Intracellular calcium parallels motor neuron degeneration in SOD1 mutant mice. J Neuropathol Exp Neurol. 1998;57:571–87.
  • Borgers M, de Brabander DM, van Reempts DJ, Awouters F, Jacob WA. Intranuclear microtubules in lung mast cells of guinea pigs in anaphylactic shock. Lab Invest. 1977;37:1–8.
  • Borgers M, Thoné F, van Neuten JM. The subcellular distribution of calcium and the effects of calcium antagonists as evaluted with a combined oxalate-pyroantimonate technique. Acta Histochem. 1981;S24:327–32.
  • Probst W. Ultrastructural localization of calcium in the CNS of vertebrates. Histochem. 1986;85:231–9.
  • Buchs P-A, Stoppini L, Párducz A, Siklós L, Muller D. A new cytochemical method for the ultrastructural localization of calcium in the central nervous system. J Neurosci Meth. 1994;54:83–93.
  • Adalbert R, Engelhardt JI, Siklós L. DL-homocysteic acid application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo. Acta Neuropathol. 2002;103:428–36.
  • Engelhardt JI, Siklós L, Appel SH. Altered calcium homeostasis and ultrastructure in motor neurons of mice caused by passively transferred anti-motoneuronal IgG. J Neuropathol Exp Neurol. 1997;56:21–39.
  • Kittel Á, Siklós L, Thuróczy G, Somosy Z. Qualitative enzyme histochemistry and microanalysis reveals changes in ultrastructural distribution of calcium and calcium-activated ATPases after microwave irradiation of the medial habenula. Acta Neuropathol. 1996;92:362–8.
  • Siklós L, Kuhnt U, Párducz Á, Szerdahelyi P. Intracellular calcium redistribution accompanies changes in total tissue Na+, K+ and water during the first two hours of in vitro incubation of hippocampal slices. Neuroscience. 1997;79: 1013–22.
  • Somosy Z, Kovács J, Siklós L, Köteles GJ. Morphological and histochemical changes in intercellular junctional complexes in epithelial cells of mouse small intestine upon X-irradiation: changes of ruthenium red permeabiliy and calcium content. Scanning Microscopy. 1993;7:961–71.
  • Siklós L, Engelhardt JI, Harati Y, Smith RG, Joó F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol. 1996;39:203–16.
  • Ludolph AC, Bendotti C, Blaugrund E, Chio A, Greensmith L, Loeffler J-P, . Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotroph Lateral Scler. 2010;11:38–45.
  • Wagner KR. The need for biomarkers in amyotrophic lateral sclerosis drug development. Neurology. 2009;72:11–2.